April 2019 Primary Care Sports Medicine Journal Roundup
The American Journal of Sports Medicine (April 2019)
-
The risk of prolonged opioid use after arthroscopic shoulder procedures is 8.3%, and it is higher among women and among those with greater opioid use in the early postoperative period, mental health conditions, substance dependence and abuse, and preexisting pain disorders
-
Nonoperatively treated (85%) and operatively treated (72%) athletes successfully returned to the same sport without injury for at least 1 full season (P = .11).
-
Players sustaining a dislocation were significantly more likely to fail to return when compared with those sustaining a subluxation (26% vs 89%, P = .013).
-
Among patients with chronic gluteal tendinopathy and a length of symptoms >15 months, a single intratendinous LR-PRP injection performed under ultrasound guidance results in greater improvement in pain and function than a single CSI.
-
The improvement after LR-PRP injection is sustained at 2 years, whereas the improvement from a CSI is maximal at 6 weeks and not maintained beyond 24 weeks.
British Journal of Sports Medicine (April Volume 7, April Volume 8)
-
The CES-D score indicated mild to moderate symptoms of depression in 48 (16.6%) and severe symptoms in 41 (14.1%) players
-
The GAD-7 score indicated an at least moderate generalised anxiety disorder in 24 (8.3%) players
-
Only a third of the 45 (15.7%) players who stated that they currently wanted or needed psychotherapeutic support received it!!
-
Physical activity declines modestly between adolescence and young adulthood
-
Athletes were often unable to achieve sleep recommendations during training or competition periods.
-
Sleep was impaired the night of competition compared with previous nights.
-
Early morning training, increases in training load, travel departure times, jet lag and altitude can impair athletes’ sleep
Sports Medicine (April 2019)
-
Only 5 of 23 substance classes show evidence of having the ability to enhance actual sports performance, i.e. anabolic agents, β2-agonists, stimulants, glucocorticoids and β-blockers.
-
One additional class, growth hormone, has similar evidence but only in untrained subjects.
-
The observed effects all relate to strength or sprint performance (and accuracy for β-blockers); there are no studies showing positive effects on reliable markers of endurance performance.
-
For 11 classes, no well-designed studies are available, and, for the remaining six classes, there is evidence of an absence of a positive effect.
-
VAD attributed to sports participation is uncommonly reported and the mechanisms are varied.
-
Impact to the mastoid region is consistently implicated in fatal cases and should be the focus of injury prevention strategies in sport.
-
There are currently no published evidence-based criteria to inform RTS decisions for patients with an LAS injury.
Sports Health Journal
-
See March/April review by clicking here